Projections of Type 1 and Type 2 Diabetes Burden in the U.S. Population Aged <20 Years Through 2060: The SEARCH for Diabetes in Youth Study.
Journal
Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975
Informations de publication
Date de publication:
01 02 2023
01 02 2023
Historique:
received:
16
05
2022
accepted:
03
11
2022
pmc-release:
01
02
2024
pubmed:
30
12
2022
medline:
31
1
2023
entrez:
29
12
2022
Statut:
ppublish
Résumé
To project the prevalence and number of youths with diabetes and trends in racial and ethnic disparities in the U.S. through 2060. Based on a mathematical model and data from the SEARCH for Diabetes in Youth study for calendar years 2002-2017, we projected the future prevalence of type 1 and type 2 diabetes among youth aged <20 years while considering different scenarios of future trends in incidence. The number of youths with diabetes will increase from 213,000 (95% CI 209,000; 218,000) (type 1 diabetes 185,000, type 2 diabetes 28,000) in 2017 to 239,000 (95% CI 209,000; 282,000) (type 1 diabetes 191,000, type 2 diabetes 48,000) in 2060 if the incidence remains constant as observed in 2017. Corresponding relative increases were 3% (95% CI -9%; 21%) for type 1 diabetes and 69% (95% CI 43%; 109%) for type 2 diabetes. Assuming that increasing trends in incidence observed between 2002 and 2017 continue, the projected number of youths with diabetes will be 526,000 (95% CI 335,000; 893,000) (type 1 diabetes 306,000, type 2 diabetes 220,000). Corresponding relative increases would be 65% (95% CI 12%; 158%) for type 1 diabetes and 673% (95% CI 362%; 1,341%) for type 2 diabetes. In both scenarios, substantial widening of racial and ethnic disparities in type 2 diabetes prevalence are expected, with the highest prevalence among non-Hispanic Black youth. The number of youths with diabetes in the U.S. is likely to substantially increase in future decades, which emphasizes the need for prevention to attenuate this trend.
Identifiants
pubmed: 36580405
pii: 148151
doi: 10.2337/dc22-0945
pmc: PMC9887625
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
313-320Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR000062
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001450
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000154
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000077
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001425
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK127208
Pays : United States
Organisme : NIDDK NIH HHS
ID : UC4 DK108173
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP006131
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP006133
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP006134
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP006136
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP006138
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP006139
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000246
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP002714
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000247
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000248
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP002709
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000254
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP002708
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000244
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U18 DP002710
Pays : United States
Organisme : NCCDPHP CDC HHS
ID : U01 DP000250
Pays : United States
Informations de copyright
© 2023 by the American Diabetes Association.
Références
JAMA. 2021 Aug 24;326(8):717-727
pubmed: 34427600
Theor Popul Biol. 2014 Mar;92:62-8
pubmed: 24333220
Pediatrics. 2020 Sep;146(3):
pubmed: 32778539
BMJ Open Diabetes Res Care. 2021 Jan;9(1):
pubmed: 33455907
MMWR Morb Mortal Wkly Rep. 2020 Feb 14;69(6):161-165
pubmed: 32053581
Diabetes Care. 2012 Dec;35(12):2515-20
pubmed: 23173134
Diabetes Care. 2021 Dec;44(12):2691-2698
pubmed: 34607833
Diabetes Care. 2007 Mar;30(3):503-9
pubmed: 17327312
Ann Epidemiol. 1997 Jul;7(5):322-33
pubmed: 9250627
Lancet Diabetes Endocrinol. 2016 Jun;4(6):537-47
pubmed: 27156051
Ann Epidemiol. 2019 Sep;37:37-42
pubmed: 31383511
Diabetes Care. 2014 Dec;37(12):3336-44
pubmed: 25414389
J Diabetes Complications. 2018 Jun;32(6):545-549
pubmed: 29685480
Control Clin Trials. 2004 Oct;25(5):458-71
pubmed: 15465616
PLoS One. 2019 Dec 17;14(12):e0226554
pubmed: 31846478
MMWR Morb Mortal Wkly Rep. 2021 Sep 17;70(37):1278-1283
pubmed: 34529635
Diabetes Care. 2018 Feb;41(2):233-240
pubmed: 29358467
Clin Diabetes Endocrinol. 2017 Jan 18;3:1
pubmed: 28702255
Diabet Med. 2019 Oct;36(10):1217-1225
pubmed: 30659656
J Adolesc Health. 2018 Nov;63(5):519-520
pubmed: 30348272
Curr Diab Rep. 2020 Aug 7;20(9):45
pubmed: 32767148
JAMA. 2017 Feb 28;317(8):825-835
pubmed: 28245334
J Clin Endocrinol Metab. 2009 Jul;94(7):2215-20
pubmed: 19584196
Diabetes Care. 2016 Sep;39(9):1635-42
pubmed: 27486237
Diabetes Care. 2020 Nov 2;:
pubmed: 33139407
JAMA. 2016 Jun 7;315(21):2292-9
pubmed: 27272581
Diabetes Care. 2008 Jul;31(7):1422-6
pubmed: 18375420